BiondVax Pharmaceuticals

-$0.01 (-0.24%) As of 2:09 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BVXV and other ETFs, options, and stocks.

About BVXV

BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on M-001, a novel flu vaccine candidate that was designed to provide multi-strain and multi-season protection against current and future, seasonal and pandemic influenza.

CEO
Amir Reichman
Employees
21
Headquarters
Jerusalem, Jerusalem
Founded
2003

BVXV Key Statistics

Market Cap
32.17M
Price-Earnings Ratio
3.80
Dividend Yield
—
Average Volume
107.47K
High Today
$2.32
Low Today
$2.24
Open Price
$2.25
Volume
13.73K
52 Week High
$43.57
52 Week Low
$2.10

BVXV Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
-$0.01 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure